Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 589 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR New on NCI Websites for December 2018 December 28, 2018 Efficacy and Safety of Entrectinib in Advanced ROS1 Fusion–Positive Non–Small Cell... March 15, 2021 Peace May 19, 2021 Checking in on our Mental Health May 14, 2021 Load more HOT NEWS Attorney Donates $30K In Gift Cards So Parents Can Purchase Gifts... Experimental Medulloblastoma Treatment Gets a Boost with Nanoparticles Precision drug slows progression of advanced breast cancer Community Surprises Teen Battling Bone Cancer With Brand New Car For...
